208 related articles for article (PubMed ID: 31967741)
1. Metachromatic leukodystrophy and transplantation: remyelination, no cross-correction.
Wolf NI; Breur M; Plug B; Beerepoot S; Westerveld ASR; van Rappard DF; de Vries SI; Kole MHP; Vanderver A; van der Knaap MS; Lindemans CA; van Hasselt PM; Boelens JJ; Matzner U; Gieselmann V; Bugiani M
Ann Clin Transl Neurol; 2020 Feb; 7(2):169-180. PubMed ID: 31967741
[TBL] [Abstract][Full Text] [Related]
2. Neurodegenerative disease after hematopoietic stem cell transplantation in metachromatic leukodystrophy.
Al-Saady M; Beerepoot S; Plug BC; Breur M; Galabova H; Pouwels PJW; Boelens JJ; Lindemans C; van Hasselt PM; Matzner U; Vanderver A; Bugiani M; van der Knaap MS; Wolf NI
Ann Clin Transl Neurol; 2023 Jul; 10(7):1146-1159. PubMed ID: 37212343
[TBL] [Abstract][Full Text] [Related]
3. Multipotential neural precursors transplanted into the metachromatic leukodystrophy brain fail to generate oligodendrocytes but contribute to limit brain dysfunction.
Givogri MI; Bottai D; Zhu HL; Fasano S; Lamorte G; Brambilla R; Vescovi A; Wrabetz L; Bongarzone E
Dev Neurosci; 2008; 30(5):340-57. PubMed ID: 18667806
[TBL] [Abstract][Full Text] [Related]
4. Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial.
Sessa M; Lorioli L; Fumagalli F; Acquati S; Redaelli D; Baldoli C; Canale S; Lopez ID; Morena F; Calabria A; Fiori R; Silvani P; Rancoita PM; Gabaldo M; Benedicenti F; Antonioli G; Assanelli A; Cicalese MP; Del Carro U; Sora MG; Martino S; Quattrini A; Montini E; Di Serio C; Ciceri F; Roncarolo MG; Aiuti A; Naldini L; Biffi A
Lancet; 2016 Jul; 388(10043):476-87. PubMed ID: 27289174
[TBL] [Abstract][Full Text] [Related]
5. Brain cell type-specific endocytosis of arylsulfatase A identifies limitations of enzyme-based therapies for metachromatic leukodystrophy.
Kaminski D; Yaghootfam C; Matthes F; Reßing A; Gieselmann V; Matzner U
Hum Mol Genet; 2021 Feb; 29(23):3807-3817. PubMed ID: 33367737
[TBL] [Abstract][Full Text] [Related]
6. Long-term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Juvenile Metachromatic Leukodystrophy Compared With Nontransplanted Control Patients.
Groeschel S; Kühl JS; Bley AE; Kehrer C; Weschke B; Döring M; Böhringer J; Schrum J; Santer R; Kohlschütter A; Krägeloh-Mann I; Müller I
JAMA Neurol; 2016 Sep; 73(9):1133-40. PubMed ID: 27400410
[TBL] [Abstract][Full Text] [Related]
7. Metachromatic leukodystrophy: Disease spectrum and approaches for treatment.
van Rappard DF; Boelens JJ; Wolf NI
Best Pract Res Clin Endocrinol Metab; 2015 Mar; 29(2):261-73. PubMed ID: 25987178
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy in metachromatic leukodystrophy.
Sevin C; Cartier-Lacave N; Aubourg P
Int J Clin Pharmacol Ther; 2009; 47 Suppl 1():S128-31. PubMed ID: 20040324
[TBL] [Abstract][Full Text] [Related]
9. Oligodendroglial progenitor cell therapy limits central neurological deficits in mice with metachromatic leukodystrophy.
Givogri MI; Galbiati F; Fasano S; Amadio S; Perani L; Superchi D; Morana P; Del Carro U; Marchesini S; Brambilla R; Wrabetz L; Bongarzone E
J Neurosci; 2006 Mar; 26(12):3109-19. PubMed ID: 16554462
[TBL] [Abstract][Full Text] [Related]
10. Correction of brain oligodendrocytes by AAVrh.10 intracerebral gene therapy in metachromatic leukodystrophy mice.
Piguet F; Sondhi D; Piraud M; Fouquet F; Hackett NR; Ahouansou O; Vanier MT; Bieche I; Aubourg P; Crystal RG; Cartier N; Sevin C
Hum Gene Ther; 2012 Aug; 23(8):903-14. PubMed ID: 22642214
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic Stem Cell Transplantation with Mesenchymal Stromal Cells in Children with Metachromatic Leukodystrophy.
Cabanillas Stanchi KM; Böhringer J; Strölin M; Groeschel S; Lenglinger K; Treuner C; Kehrer C; Laugwitz L; Bevot A; Kaiser N; Schumm M; Lang P; Handgretinger R; Krägeloh-Mann I; Müller I; Döring M
Stem Cells Dev; 2022 Apr; 31(7-8):163-175. PubMed ID: 35323019
[TBL] [Abstract][Full Text] [Related]
12. Lysosomal leukodystrophies: Krabbe disease and metachromatic leukodystrophy.
Kohlschütter A
Handb Clin Neurol; 2013; 113():1611-8. PubMed ID: 23622382
[TBL] [Abstract][Full Text] [Related]
13. Developing therapeutic approaches for metachromatic leukodystrophy.
Patil SA; Maegawa GH
Drug Des Devel Ther; 2013; 7():729-45. PubMed ID: 23966770
[TBL] [Abstract][Full Text] [Related]
14. Long-term neuroimaging follow-up on an asymptomatic juvenile metachromatic leukodystrophy patient after hematopoietic stem cell transplantation: evidence of myelin recovery and ongoing brain maturation.
Ding XQ; Bley A; Kohlschütter A; Fiehler J; Lanfermann H
Am J Med Genet A; 2012 Jan; 158A(1):257-60. PubMed ID: 22140054
[No Abstract] [Full Text] [Related]
15. Apolipoprotein E genotype and LRP1 polymorphisms in patients with different clinical types of metachromatic leukodystrophy.
Ługowska A; Musielak M; Jamroz E; Pyrkosz A; Kmieć T; Tylki-Szymańska A; Bednarska-Makaruk M
Gene; 2013 Sep; 526(2):176-81. PubMed ID: 23701968
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes after allogeneic hematopoietic stem cell transplantation for metachromatic leukodystrophy: the largest single-institution cohort report.
Boucher AA; Miller W; Shanley R; Ziegler R; Lund T; Raymond G; Orchard PJ
Orphanet J Rare Dis; 2015 Aug; 10():94. PubMed ID: 26245762
[TBL] [Abstract][Full Text] [Related]
17. Correction of metachromatic leukodystrophy in the mouse model by transplantation of genetically modified hematopoietic stem cells.
Biffi A; De Palma M; Quattrini A; Del Carro U; Amadio S; Visigalli I; Sessa M; Fasano S; Brambilla R; Marchesini S; Bordignon C; Naldini L
J Clin Invest; 2004 Apr; 113(8):1118-29. PubMed ID: 15085191
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of hematopoietic cell transplantation in metachromatic leukodystrophy: the Dutch experience.
van Rappard DF; Boelens JJ; van Egmond ME; Kuball J; van Hasselt PM; Oostrom KJ; Pouwels PJ; van der Knaap MS; Hollak CE; Wolf NI
Blood; 2016 Jun; 127(24):3098-101. PubMed ID: 27118454
[No Abstract] [Full Text] [Related]
19. Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access.
Fumagalli F; Calbi V; Natali Sora MG; Sessa M; Baldoli C; Rancoita PMV; Ciotti F; Sarzana M; Fraschini M; Zambon AA; Acquati S; Redaelli D; Attanasio V; Miglietta S; De Mattia F; Barzaghi F; Ferrua F; Migliavacca M; Tucci F; Gallo V; Del Carro U; Canale S; Spiga I; Lorioli L; Recupero S; Fratini ES; Morena F; Silvani P; Calvi MR; Facchini M; Locatelli S; Corti A; Zancan S; Antonioli G; Farinelli G; Gabaldo M; Garcia-Segovia J; Schwab LC; Downey GF; Filippi M; Cicalese MP; Martino S; Di Serio C; Ciceri F; Bernardo ME; Naldini L; Biffi A; Aiuti A
Lancet; 2022 Jan; 399(10322):372-383. PubMed ID: 35065785
[TBL] [Abstract][Full Text] [Related]
20. Metachromatic leukodystrophy. Report of siblings with the juvenile type of metachromatic leukodystrophy.
Satoh T; Suzuki H; Monma N; Satodate R; Tanaka H; Yajima H
Acta Pathol Jpn; 1988 Aug; 38(8):1041-51. PubMed ID: 3188912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
